Stem Cell Research
Embryonic stem cell-derived embryoid body development improved by stirred vessel culture
Published in Blood Weekly, September 21st, 2006
According to recent research published in the journal Biotechnology and Bioengineering, "Human embryonic stem cells (hESCs) represent an important resource for novel cell-based regenerative medical therapies.
"hESCs are known to differentiate into mature cells of defined lineages through the formation of embryoid bodies (EBs) which are amenable to suspension culture for several weeks. However, EBs derived from hESCs in standard static cultures are typically nonhomogeneous, leading to inefficient cellular development."
"Here,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-09-21)
More Articles from Blood Weekly
- Septic Shock
Septic shock prognosis linked with increased plasma brain natriuretic peptide levels - Tissue Engineering
Autologous full-thickness skin substitute heals chronic wounds - Tissue Engineering
Chondrocytes from older donors can be rejuvenated and can produce neocartilage - Tissue Engineering
Dendrimer crosslinked collagen gels may be suitable scaffolds for corneal tissue engineering - Tissue Engineering
Nanocomposite microvessels developed for artificial capillary bed - Acute Myeloid Leukemia
Acute myeloid leukemia cell beta-catenin expression predicts poor prognosis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
